NCT06459934 Clinical Outcomes of Cardiovascular Disease
| NCT ID | NCT06459934 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xinjiang Medical University |
| Condition | Cardiovascular Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 30,000 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30,000 participants in total. It began in 2024-06-01 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a prospective, single center cohort study that primarily registers the clinical characteristics, outcomes, and influencing factors of patients with different types of cardiovascular diseases. Evaluate multiple examination indicators of patients at baseline, 1 year and longer, and follow up on the incidence of major cardiovascular and cerebrovascular adverse events, heart failure readmission, death, and other endpoint events.
Eligibility Criteria
Inclusion Criteria: 1. Coronary heart disease According to coronary angiography and coronary CTA, at least one coronary artery has a degree of stenosis greater than 50%. 2. Hypertension Hypertension is defined as office systolic blood pressure is ≥ 140mmHg and/or the diastolic blood pressure is ≥ 90mmHg without the use of antihypertensive drugs. 3. Heart failure There is a clear history of organic heart disease, clinical symptoms and signs of heart failure, and objective evidence of heart failure. 4. Cardiomyopathy Including defined dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, etc. 5. Able to sign informed consent form. Exclusion Criteria: 1. Age\<18 years old, or\>80 years old. 2. Patients with various malignant tumors. 3. Liver dysfunction (defined as ALT or total bilirubin greater than three times the upper normal limit). 4. Renal insufficiency (defined as blood creatinine exceeding 1.5 times the upper normal limit). 5. Those who have participated in other clinical studies within the past three months. 6. Individuals without legal capacity or with limited legal capacity. 7. Any situation where the researcher deems it unsuitable to participate in the clinical study.
Contact & Investigator
Xiang Xie, Prof
PRINCIPAL INVESTIGATOR
Xinjiang Medical University
Frequently Asked Questions
Who can join the NCT06459934 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06459934 currently recruiting?
Yes, NCT06459934 is actively recruiting participants. Contact the research team at zhengying527@163.com for enrollment information.
Where is the NCT06459934 trial being conducted?
This trial is being conducted at Ürümqi, China.
Who is sponsoring the NCT06459934 clinical trial?
NCT06459934 is sponsored by Xinjiang Medical University. The principal investigator is Xiang Xie, Prof at Xinjiang Medical University. The trial plans to enroll 30,000 participants.